• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: COOPERVISION MANUFACTURING, LTD. PROCLEAR MULTIFOCAL (OMAFILCON B); PROCLAER MULTIFOCAL (OMAFILCON B)

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

COOPERVISION MANUFACTURING, LTD. PROCLEAR MULTIFOCAL (OMAFILCON B); PROCLAER MULTIFOCAL (OMAFILCON B) Back to Search Results
Lot Number 16734050013014
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Corneal Edema (1791); Keratitis (1944); Red Eye(s) (2038); Burning Sensation (2146)
Event Date 04/20/2020
Event Type  Injury  
Manufacturer Narrative
No product was returned to the manufacturer for device evaluation.A lot number was received, lot history, device history, sterilization records and trend reporting were reviewed.No issues or nonconformance's were found and no trends were identified, no root cause could be established.The relationship between the coopervision device and the incident is unconfirmed.
 
Event Description
It is reported that the patient experienced symptoms of a burning sensation, irritation and periorbital pain of the right (od) eye on (b)(6) 2020 and sought medical treatment.The patient presented with severe epithelial staining, moderate epithelial edema, limbal and bulbar injection, and trace stromal edema.Fluorescein staining identified central spk and a central epithelial defect.The patient was prescribed polytrim, prednisolone 1%, and motrin initially.The following day an amniotic membrane was placed on the right eye.Over the course of treatment and doxycycline and muro 128 were also prescribed.As of (b)(6), all medications and treatments were concluded and the incident fully resolved, however, the treating physician indicates that medical intervention and/or medications were required to prevent or preclude permanent impairment of eye function or structure from the condition of a persistent epithelial defect.
 
Manufacturer Narrative
Based on investigation, no issues or nonconformance's were found and no trends were identified, no root cause could be established.The relationship between the coopervision device and the incident is unconfirmed.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PROCLEAR MULTIFOCAL (OMAFILCON B)
Type of Device
PROCLAER MULTIFOCAL (OMAFILCON B)
Manufacturer (Section D)
COOPERVISION MANUFACTURING, LTD.
south point
hamble unit 2
southamptom, hampshire SO31 4RF
UK  SO31 4RF
MDR Report Key10277850
MDR Text Key199884970
Report Number9614392-2020-00012
Device Sequence Number1
Product Code LPL
Combination Product (y/n)N
PMA/PMN Number
K123202
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional
Type of Report Initial,Followup
Report Date 09/04/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received07/15/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Device Expiration Date12/31/2023
Device Lot Number16734050013014
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer07/27/2020
Date Manufacturer Received06/16/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Other; Required Intervention;
Patient Age53 YR
Patient Weight68
-
-